Market Cap 42.72M
Revenue (ttm) 90,000.00
Net Income (ttm) -46.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -52,100.00%
Debt to Equity Ratio 0.00
Volume 71,400
Avg Vol 181,540
Day's Range N/A - N/A
Shares Out 11.97M
Stochastic %K 86%
Beta 6.98
Analysts Hold
Price Target $18.00

Company Profile

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety diso...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 61 4 0984 0786
Address:
8 Century Circuit, Suite 105 Norwest, Sydney, Australia
Pipparis
Pipparis Aug. 24 at 3:31 PM
0 · Reply
RollTheDice369
RollTheDice369 Aug. 24 at 3:15 PM
$IXHL Why are you green? Yes.
0 · Reply
RogueFF7
RogueFF7 Aug. 24 at 3:00 PM
$IXHL This past week. Money is rotating. Apnimed had a great IPO run though. After being rejected at $36 it’s been trending down. Nice 100% gain for those who sold in the 30s. I moved profits into my core IXHL position. We are quietly grinding higher.
0 · Reply
Rampart1
Rampart1 Aug. 24 at 2:56 PM
$IXHL new high! slow but good.
0 · Reply
meanrebel
meanrebel Aug. 24 at 2:49 PM
0 · Reply
RogueFF7
RogueFF7 Aug. 24 at 2:22 PM
$IXHL Excellent thread. This combined with Polar’s exit explains why the selling pressure is over. Waiting on First Patient Dosed. Bulls are in control.
0 · Reply
BarfsterWoolSmittens
BarfsterWoolSmittens Aug. 24 at 12:23 PM
0 · Reply
stockro1
stockro1 Aug. 24 at 11:08 AM
$IXHL interestingly quiet this morning…
4 · Reply
SeamuSMingluS
SeamuSMingluS Aug. 24 at 8:30 AM
$IXHL Cheers Surfy 🙂 I appreciate the enthusiasm shown by many but also good to keep a strong rebuttal going to avoid Echo Chambers like the past. Heres just a snippet its data like this thats interesting to compare our 42X First in class drug to. Especially important to look past the Company pumpers with the Generic POC study results intertwined into the resonating narrative. 50.7% is not what reposa showed. Reposa was 13.9 % and 14.7% >50% AHI reduction 39% and 41% was the group above 33% Now look at the other studies. https://pmc.ncbi.nlm.nih.gov/articles/PMC7768933/ Interesting stuff Nobody talks about science or FDA combination rules, Just unicorns and fairy tales Wow IXHL to the moon Resmeds Novospheres Its all happening now. Talk has already pivoted in last interview to Commercial discussions about Pathways and Pipelines we dont have under development that have never been tested on humans. Were valued and ZIP NADA in 2022 🫠🫠🫠 Pathways
0 · Reply
D_Ko
D_Ko Aug. 24 at 3:55 AM
$IXHL so what really happened to our CEO... He look different with a penis in his mouth
1 · Reply
Latest News on IXHL
Incannex receives additional A$5.1M R&D tax incentive refund

2026-08-11T13:25:55.000Z - 13 days ago

Incannex receives additional A$5.1M R&D tax incentive refund


Incannex commences screening in DReAMzz trial

2026-07-23T12:10:52.000Z - 4 weeks ago

Incannex commences screening in DReAMzz trial


Incannex granted IHL-42X composition patent by USPTO

2026-06-25T12:10:38.000Z - 2 months ago

Incannex granted IHL-42X composition patent by USPTO


Incannex receives A$6.04M tax incentive refund

2026-06-10T12:06:25.000Z - 2 months ago

Incannex receives A$6.04M tax incentive refund


Incannex initiated with a Buy at Alliance Global

2026-06-08T11:05:32.000Z - 2 months ago

Incannex initiated with a Buy at Alliance Global


Incannex Healthcare Quarterly report: Q3 2026

May 15, 2026, 7:00 AM EDT - 3 months ago

Incannex Healthcare Quarterly report: Q3 2026


Incannex commences DReaMzz clinical study of IHL-42X in OSA

2026-05-14T19:10:49.000Z - 3 months ago

Incannex commences DReaMzz clinical study of IHL-42X in OSA


Incannex reactivates share repurchase program

2026-03-27T12:12:54.000Z - 5 months ago

Incannex reactivates share repurchase program


Incannex reports balance sheet with $75M in cash, no debt

2026-03-18T12:27:15.000Z - 5 months ago

Incannex reports balance sheet with $75M in cash, no debt


Incannex regains compliance with Nasdaq minimum bid price rule

2026-03-17T12:16:04.000Z - 5 months ago

Incannex regains compliance with Nasdaq minimum bid price rule


Incannex announces enhanced development strategy for IHL-42X

2026-03-12T12:21:15.000Z - 5 months ago

Incannex announces enhanced development strategy for IHL-42X


Incannex Healthcare Inc trading halted, news pending

2026-02-27T00:50:18.000Z - 6 months ago

Incannex Healthcare Inc trading halted, news pending


Incannex board approves 1-for-30 reverse stock split

2026-02-25T14:29:04.000Z - 6 months ago

Incannex board approves 1-for-30 reverse stock split


Incannex Announces Reverse Stock Split

Feb 25, 2026, 9:20 AM EST - 6 months ago

Incannex Announces Reverse Stock Split


Incannex Healthcare Slides: Investor presentation

Feb 20, 2026, 6:00 AM EST - 6 months ago

Incannex Healthcare Slides: Investor presentation


Incannex Healthcare Quarterly report: Q2 2026

Feb 13, 2026, 7:00 AM EST - 6 months ago

Incannex Healthcare Quarterly report: Q2 2026


Incannex Healthcare Proxy statement: Proxy Filing

Dec 18, 2025, 7:00 AM EST - 8 months ago

Incannex Healthcare Proxy statement: Proxy Filing


Incannex Healthcare Proxy statement: Proxy Filing

Dec 16, 2025, 7:00 AM EST - 8 months ago

Incannex Healthcare Proxy statement: Proxy Filing


Incannex Healthcare Quarterly report: Q1 2026

Nov 14, 2025, 4:00 PM EST - 10 months ago

Incannex Healthcare Quarterly report: Q1 2026


Incannex Healthcare Proxy statement: Proxy Filing

Oct 27, 2025, 8:00 AM EDT - 10 months ago

Incannex Healthcare Proxy statement: Proxy Filing


Incannex Healthcare Proxy statement: Proxy Filing

Oct 27, 2025, 8:00 AM EDT - 10 months ago

Incannex Healthcare Proxy statement: Proxy Filing


Incannex Healthcare Annual report: Q4 2025

Sep 29, 2025, 9:30 AM EDT - 11 months ago

Incannex Healthcare Annual report: Q4 2025


Incannex Healthcare Proxy statement: Proxy Filing

May 16, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Proxy statement: Proxy Filing


Incannex Healthcare Earnings release: Q3 2025

May 15, 2025, 9:30 AM EDT - 1 year ago

Incannex Healthcare Earnings release: Q3 2025


Incannex Healthcare Quarterly report: Q3 2025

May 15, 2025, 9:30 AM EDT - 1 year ago

Incannex Healthcare Quarterly report: Q3 2025


Incannex Healthcare Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Proxy statement: Proxy Filing


Incannex Healthcare Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Proxy statement: Proxy Filing


Incannex Healthcare Proxy statement: Proxy Filing

Mar 18, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Proxy statement: Proxy Filing


Incannex Healthcare Earnings release: Q2 2025

Feb 14, 2025, 7:00 AM EST - 1 year ago

Incannex Healthcare Earnings release: Q2 2025


Incannex Healthcare Quarterly report: Q2 2025

Feb 14, 2025, 7:00 AM EST - 1 year ago

Incannex Healthcare Quarterly report: Q2 2025


Pipparis
Pipparis Aug. 24 at 3:31 PM
0 · Reply
RollTheDice369
RollTheDice369 Aug. 24 at 3:15 PM
$IXHL Why are you green? Yes.
0 · Reply
RogueFF7
RogueFF7 Aug. 24 at 3:00 PM
$IXHL This past week. Money is rotating. Apnimed had a great IPO run though. After being rejected at $36 it’s been trending down. Nice 100% gain for those who sold in the 30s. I moved profits into my core IXHL position. We are quietly grinding higher.
0 · Reply
Rampart1
Rampart1 Aug. 24 at 2:56 PM
$IXHL new high! slow but good.
0 · Reply
meanrebel
meanrebel Aug. 24 at 2:49 PM
0 · Reply
RogueFF7
RogueFF7 Aug. 24 at 2:22 PM
$IXHL Excellent thread. This combined with Polar’s exit explains why the selling pressure is over. Waiting on First Patient Dosed. Bulls are in control.
0 · Reply
BarfsterWoolSmittens
BarfsterWoolSmittens Aug. 24 at 12:23 PM
0 · Reply
stockro1
stockro1 Aug. 24 at 11:08 AM
$IXHL interestingly quiet this morning…
4 · Reply
SeamuSMingluS
SeamuSMingluS Aug. 24 at 8:30 AM
$IXHL Cheers Surfy 🙂 I appreciate the enthusiasm shown by many but also good to keep a strong rebuttal going to avoid Echo Chambers like the past. Heres just a snippet its data like this thats interesting to compare our 42X First in class drug to. Especially important to look past the Company pumpers with the Generic POC study results intertwined into the resonating narrative. 50.7% is not what reposa showed. Reposa was 13.9 % and 14.7% >50% AHI reduction 39% and 41% was the group above 33% Now look at the other studies. https://pmc.ncbi.nlm.nih.gov/articles/PMC7768933/ Interesting stuff Nobody talks about science or FDA combination rules, Just unicorns and fairy tales Wow IXHL to the moon Resmeds Novospheres Its all happening now. Talk has already pivoted in last interview to Commercial discussions about Pathways and Pipelines we dont have under development that have never been tested on humans. Were valued and ZIP NADA in 2022 🫠🫠🫠 Pathways
0 · Reply
D_Ko
D_Ko Aug. 24 at 3:55 AM
$IXHL so what really happened to our CEO... He look different with a penis in his mouth
1 · Reply
Santa_Claus_Trades
Santa_Claus_Trades Aug. 24 at 2:20 AM
$IXHL I can't believe it's been a month already since we initiated screening in 14 cities with 5 to 7 clinics starting the process. So...... Since screening started four weeks ago, initial candidates should be finishing their baseline assessments right now. IMO Only....​We should expect an official press release or SEC filing announcing the First Patient Dosed, within the next 1 to 3 weeks late Aug to early Sept 2026, assuming standard screening completion rates without unexpected delays. Basing this on 12 other biotech stocks within same time frame and almost identical catalysts that have taken place. This is the norm. The company, if it follows the rules, must file this information, as it is definitely a material event. If in fact we stay on track like multiple other biotechs have accomplished, I will start my third tranche of buying tomorrow. I have 5K at $2.55. 3K at $2.89. I will try and catch 3K more the lowest I can up until first dose news. NFA. Jmo. Trade for yourselves.
4 · Reply
SeamuSMingluS
SeamuSMingluS Aug. 24 at 1:01 AM
0 · Reply
SeamuSMingluS
SeamuSMingluS Aug. 24 at 12:54 AM
$IXHL Yeah its going to fly on that news. I still confused as to wether the Drug works well enough at all. Low dose synergistic mechanisms of action seem very flat on the response curve even with a 100% increase in composition only a 0.8 % difference in the very mild 13.9-14.7 % over 50% reduction Statistically thats only < 1/3 as effective as the POC study in Australia. Now looking back to topline when the company’s dumped 9.1m shares into the " EXCEEDED EXPECTATIONS" News that was filed. Also " COMMERCIAL DISCUSSIONS UPDATE IN THIS REGARD SOON" Specifically related to 42X Really the trial looks to have been a bit of a failure and the whole DREAMZZ is a rescue mission to keep the lights on. Is a 14.7 % group of patients enough to justify a pill much more expensive than a Generic Acetazolamide tablet? Would this combination be able to pass the FDA combination rule? Seems like the Acetazolamide has reached a biological ceiling and the Dronabinol is only making it complicated
2 · Reply
Stock_Catcher
Stock_Catcher Aug. 24 at 12:23 AM
Money Monday Watchlist - Let's Bounce $GNS $IXHL $DVLT $DFLI $BATL
0 · Reply
D_Ko
D_Ko Aug. 24 at 12:07 AM
$IXHL With Joels lackluster performance it's only a matter of time until Polar Asset Management lower the strike price. In turn increasing total dilution risk for existing shareholders because it makes the warrants much easier to exercise. Joel is a failure and is only good for stealing shareholders money like his criminal father Joel.
2 · Reply
malibu_rum67
malibu_rum67 Aug. 23 at 11:10 PM
$IXHL … GOLDEN😈
0 · Reply
Gigi96
Gigi96 Aug. 23 at 6:00 PM
$IXHL amazing weeke ahead?
0 · Reply
SurfyKnagg
SurfyKnagg Aug. 23 at 2:24 PM
$IXHL Looking forward to next week! First patient dosed? I'm sure we're upto date on Joels interviews and discussions with media outlets. Albeit expect some fluff, but we can't be far away now.
0 · Reply
RogueFF7
RogueFF7 Aug. 23 at 2:20 PM
$IXHL 💯 word will get around. Even though the study is blind. Patients will know when they had incredible sleep and when they didn’t. It will not be difficult putting two and two together. No NDA and people chat.
0 · Reply
SeamuSMingluS
SeamuSMingluS Aug. 23 at 1:06 PM
$IXHL Pathways to weath destruction
0 · Reply
Wildacorn
Wildacorn Aug. 23 at 12:19 PM
$IXHL Looking for a good week
0 · Reply
RogueFF7
RogueFF7 Aug. 22 at 11:54 AM
$IXHL @Jaysxph 💯. Exactly plus IHL-42X has a much lower AE so it may become the pill of choice by prescribing Doctors.
0 · Reply